Life-threatening Neuroleptic Malignant Syndrome and Its Mechanism

Takahiko Nagamine^{1

2}

Affiliations

¹ Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Japan.
² Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan.

Takahiko Nagamine. Intern Med. 2025.

. 2025 Apr 1;64(7):985-986.

doi: 10.2169/internalmedicine.4410-24. Epub 2024 Sep 4.

Takahiko Nagamine^{1

2}

¹ Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Japan.
² Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan.

No abstract available

Keywords: calcium; hypodopaminergic state; immune regulation; neuroleptic malignant syndrome; rhabdomyolysis.

Conflict of interest statement

The author states that he has no Conflict of Interest (COI).

1. Yoneyama N, Hamada S, Shimono T, Nakajima M. Widespread muscle calcification due to neuroleptic malignant syndrome. Inter Med 64: 1127-1128, 2025. - PMC - PubMed
1. Komoriya H, Nomura K, Shirata T, et al. A fatal case of fulminant neuroleptic malignant syndrome: a case report. PCN Rep 2: e75, 2023. - PMC - PubMed
1. Hadjis T, Grieff M, Lockhat D, Kaye M. Calcium metabolism in acute renal failure due to rhabdomyolysis. Clin Nephrol 39: 22-27, 1993. - PubMed
1. Mirza ZB, Hu S, Amorosa LF. Bone scintigraphy of severe hypercalcemia following simvastatin induced rhabdomyolysis. Clin Cases Miner Bone Metab 13: 257-261, 2016. - PMC - PubMed
1. Kuhlwilm L, Schönfeldt-Lecuona C, Gahr M, Connemann BJ, Keller F, Sartorius A. The neuroleptic malignant syndrome - a systematic case series analysis focusing on therapy regimes and outcome. Acta Psychiatr Scand 142: 233-241, 2020. - PubMed